Ascendis Pharma raised €48M in a Series C round in Dec 2014. The company is based in Hellerup, Denmark. Investors in the round: Sofinnova Partners, Venrock. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
